Calcium 2-aminoethylphosphate what this drug is. Calcium 2-AEP is manufactured by numerous nutraceutical companies and is sold online and in health food stores. Calcium 2-aminoethylphosphate Calcium 2-aminoethylphosphate (Ca-AEP or Ca-2AEP) is a vital component in the structure of cell membranes in the human body. It is the calcium salt of phosphorylethanolamine. It was discovered by the eminent biochemist Erwin Chargaff in 1941. Ca-AEP has been shown to help maintain cell membrane integrity and improve cellular functions. It was patented by Hans Alfred Nieper and Franz Kohler. Calcium 2-amino ethyl phosphoric acid (Ca-AEP or Ca-2AEP) is also called calcium ethylamino-phosphate (calcium EAP), calcium
Calcium in biology effective January 1, 2010. Examples of allowed wording are shown below. In order to qualify for the calcium health claim, a dietary supplement much contain at least 20% of the Reference Dietary Intake, which for calcium means at least 260 mg/serving. In 2005 the FDA approved a Qualified Health Claim for calcium and hypertension, with suggested wording "Some scientific evidence suggests that calcium supplements may reduce the risk of hypertension. However, FDA has determined that the evidence is inconsistent and not conclusive." Evidence for pregnancy-induced hypertension and preeclamsia was considered inconclusive. The same year the FDA approved a QHC for